Synthesis, checkpoint kinase 1 inhibitory properties and in vitro antiproliferative activities of new pyrrolocarbazoles

Access to 5-Methyl-5H-naphtho[2,3-c]carbazole-8,13-dione Derivatives via Copper-Catalyzed Intramolecular Isomerization

Carbazole-fused quinones are important compounds for their potential pharmacological activities and photophysical properties. Here, a novel copper-catalyzed intramolecular isomerization process to access a new class of naphtho[2,3-c]carbazole-8,13-dione derivatives via a furan isomerization/γ-H elimination and β-C elimination/6π-electrocyclization/aromatization cascade is reported. Furthermore, the preliminary photophysical properties of the functional 5-methyl-5H-naphtho[2,3-c]carbazole-8,13-dione derivatives have been studied.

Remote N–H activation of indole aldehydes: an investigation of the mechanism, origin of selectivities, and role of the catalyst

Density functional theory investigation on the N-heterocyclic carbene-catalysed synthesis of oxazinoindole derivatives via N–H activation of indole aldehydes.

Water Modulated Diastereoselective Synthesis of cis/trans-Spiro[indoline-3,6'-naphtho[2,3-c]carbazoles]

p-TsOH catalyzed Diels-Alder reaction of 2-(1-alkylindol-3-yl)naphthalene-1,4-diones and 3-phenacylideneoxindoles showed fascinating diastereoselectivity. The reaction with the hydrated p-TsOH afforded trans-isomers of dihydrospiro[indoline-3,6'-naphtho[2,3-c]carbazoles] as major products. Alternatively, the reaction with anhydrous p-TsOH under a Dean and Stark apparatus predominately gave cis-isomer of dihydrospiro[indoline-3,6'-naphtho[2,3-c]carbazoles]. On the other hand, the similar p-TsOH catalyzed reaction of 2-(indol-3-yl)naphthalene-1,4-diones with 3-arylideneindolin-2-ones afforded cis/trans-isomers of dihydrospiro[indoline-3,6'-naphtho[2,3-c]carbazoles]. Additionally, the p-TsOH catalyzed reaction of 2-(indol-3-yl)naphthalene-1,4-diones with 2-arylidene-1,3-indanediones gave the expected spiro[indene-2,6'-naphtho[2,3-c]carbazoles] in satisfactory yields.

Carbazole Derivatives as Kinase-Targeting Inhibitors for Cancer Treatment

Protein Kinases (PKs) are a heterogeneous family of enzymes that modulate several biological pathways, including cell division, cytoskeletal rearrangement, differentiation and apoptosis. In particular, due to their crucial role during human tumorigenesis and cancer progression, PKs are ideal targets for the design and development of effective and low toxic chemotherapeutics and represent the second group of drug targets after G-protein-coupled receptors. Nowadays, several compounds have been claimed to be PKs inhibitors, and some of them, such as imatinib, erlotinib and gefitinib, have already been approved for clinical use, whereas more than 30 others are in various phases of clinical trials. Among them, some natural or synthetic carbazole-based molecules represent promising PKs inhibitors due to their capability to interfere with PK activity by different mechanisms of action including the ability to act as DNA intercalating agents, interfere with the activity of enzymes involved in DNA duplication, such as topoisomerases and telomerases, and inhibit other proteins such as cyclindependent kinases or antagonize estrogen receptors. Thus, carbazoles can be considered a promising this class of compounds to be adopted in targeted therapy of different types of cancer.

A new strategy for the synthesis of diverse benzo[a]carbazoles via a divergent catalytic Michael reaction

A new type of divergent catalytic Michael addition reaction of α,α-dicyanomethylidene carbazoles afforded multifunctional benzo[a]carbazoles in good yields.

Marine pyrrolocarbazoles and analogues: synthesis and kinase inhibition

Granulatimide and isogranulatimide are alkaloids obtained from marine sources which have been shown to inhibit cell-cycle G2-checkpoint, targeting more particularly checkpoint 1 kinase (Chk1). At a structural level, they possess a characteristic pyrrolocarbazole framework also shared by the well-known rebeccamycin and staurosporine microbial metabolites which have been described to inhibit topoisomerase I and diverse kinases, respectively. This review reports precisely on the synthesis and kinase inhibitory activities of pyrrolocarbazole-based analogues of granulatimide.